(Total Views: 207)
Posted On: 08/07/2019 3:40:41 PM
Post# of 128860

$CLBS News Article - Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina https://marketwirenews.com/news-releases/cala...83055.html


My Twitter: WhyteStocks